A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem

Abuse Potential Clinical Trial

Official title:
A Single-Dose, Double-Blind, Placebo-Controlled, Randomized, Crossover Study to Determine the Abuse Potential of Single Oral Dose of Seltorexant Compared To Suvorexant and Zolpidem

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the abuse potential of seltorexant compared to placebo and two active comparators (zolpidem and suvorexant) in non-dependent, recreational sedative users.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Abuse Potential

Clinical Trial Details

NCT number	NCT05106153
Study type	Interventional
Source	Janssen Research & Development, LLC
Contact
Status	Completed
Phase	Phase 1
Start date	December 17, 2021
Completion date	May 12, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06097676` - An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users	Phase 4
Terminated	`NCT03200080` - A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users	Phase 1
Completed	`NCT04570436` - Evaluating the Abuse Potential of NEURONTIN® When Taken Orally in Healthy Non-drug Dependent Participants With Sedative Drug Abuse Experience	Phase 4
Completed	`NCT05053126` - Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users	Phase 4
Completed	`NCT06247488` - Evaluation of Abuse Potential of HORIZANT Taken Alone and With Oxycodone in Healthy, Nondependent Recreational Opioid Users	Phase 4
Completed	`NCT05319756` - Study Evaluating the Abuse Potential of NEURONTIN® in Healthy Non-drug Dependent, Recreational Opioid Users	Phase 4